Glucagon-Like Peptide-2: Update of the Recent Clinical Trials
- 28 February 2006
- journal article
- review article
- Published by Elsevier in Gastroenterology
- Vol. 130 (2) , S127-S131
- https://doi.org/10.1053/j.gastro.2005.09.068
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in miceGut, 2004
- Short bowel, short answer?Gut, 1999
- Inhibition of Sham Feeding-Stimulated Human Gastric Acid Secretion by Glucagon-Like Peptide-2Journal of Clinical Endocrinology & Metabolism, 1999
- Glucagon-Like Peptide-2 Inhibits Centrally Induced Antral Motility in PigsScandinavian Journal of Gastroenterology, 1998
- ENTEROGLUCAGONAnnual Review of Physiology, 1997
- Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IVNature Biotechnology, 1997
- The Short Bowel Syndrome: What’s New and Old?Digestive Diseases, 1993
- Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel.Gut, 1992
- Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.Journal of Clinical Investigation, 1987
- Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gutFEBS Letters, 1987